Bio-Genex Laboratories, Inc.

Bio-Genex Laboratories, Inc.

BGNX
Bio-Genex Laboratories, Inc.US flagOther OTC
0.00
USD
+0.00
- -

Bio-Genex Laboratories, Inc. (BGNX) Stock Split History

Learn about Bio-Genex Laboratories, Inc.'s most recent 1-for-500 basis stock split on June 19, 2009. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Bio-Genex Laboratories, Inc.'s most recent stock split

Split Date: 2009-06-19
Split Ratio: 1:500
Price Before Split: N/A
Price After Split: N/A

Developer API

Get BGNX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/BGNX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 500.00 times fewer shares (a 1:500 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Bio-Genex Laboratories, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2009-06-191:500YesN/AN/A
2007-03-16100:1NoN/AN/A

About Bio-Genex Laboratories, Inc.

Company overview and industry information

Bio-Genex Laboratories, Inc. (BGNX) operates in the Medical - Diagnostics & Research industry. The recent 1-for-500 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Medical - Diagnostics & Research
Go to Bio-Genex Laboratories, Inc. Summary

Last updated: 7/19/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.